Sporadic
adenomas are said to exhibit an orderly growth pattern with a reversal of proliferative and apoptotic cell distribution as compared with normal colonic crypts. Dysplastic
polyps of patients with
ulcerative colitis (UC) may represent dysplasia-associated lesions or masses (
DALM) with a high associated
cancer risk, or, alternatively, may represent sporadic
adenomas. Histologic criteria to differentiate between sporadic
adenomas and
DALM have not focused on the balance between cell renewal and cell loss. The expression of the novel anti-apoptosis gene product,
survivin, and the proliferation markers, Ki-67 and Y-box
binding protein (YB-1), were investigated by immunohistochemical localization in sporadic
adenomas and
DALM lesions of patients with UC. In
adenomas, KI-67 was expressed preponderantly at the
luminal aspect of the
polyp, whereas its expression was diffuse in
DALM.
Survivin was detected diffusely in both
adenomas and
DALM. YB-1 showed positive staining in the deep aspect of adenomatous glands but only to a minor degree at the surface, whereas both deep and diffuse expression patterns of YB-1 were seen in
DALM. The authors conclude that
DALM and sporadic
adenomas exhibit different patterns of cellular proliferation and that molecular markers of cell proliferation, Ki-67 and YB-1, may be useful to distinguish sporadic
adenomas from
DALM. However, the similar expression of
survivin suggests that the underlying mechanisms that regulate apoptotic cell death are uniform in these lesions.